C P Pokphand (CPPKY) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : C P Pokphand (CPPKY)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: VivB who wrote (215)	4/26/1999 2:11:00 PM
From: VivB	Read Replies (1) of 276

Today I was listening to Power Lunch on CNBC and they were talking about Embrex, Inc.'s new poultry vaccine which can be used on chicken embroyos before hatching. The company is planning to start selling their vaccine overseas. Well, looks like the CP Group is going to be one of those first "overseas" customers: Embrex To Provide Injection Sys, Vaccine To Poultry Producer Dow Jones Newswires April 13, 1999 RESEARCH TRIANGLE PARK, N.C. -- Embrex Inc. (EMBX) agreed to provide its Bursaplex vaccine and Inovoject injection system to Chareon Pokphand Group's Bangkok Livestock Processing Co. unit. t is an egg injection system that eliminates the need for manual vaccination of newly hatched broiler chicks. In a press release Tuesday, Embrex said the unit will use Inovoject to inject the infectious bursal disease vaccine complex in ovo, beginning this month. Embrex, an agricultural biotechnology company, develops pharmaceutical and data management products to improve bird health and reduce production costs for the poultry industry. Chareon Pokphand Group is a poultry producer. Copyright Dow Jones Newswire, April 13, 1999

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next